Rhodes Jason P

Epizyme, Inc.

President, CFO and Treasurer

Avg. Two Year Performance

No Purchase Track Record

63% Avg. Sale Return 28% Compound

Holdings: 138.0K shares

Last Three Months: 22-Aug-24 -- 21-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

22-Nov-22 -- 21-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions